🔎 FLAŞ İNDİRİM: InvestingPro %50 indirimli | Başkalarının göremediğini görün, güvenle işlem yapın.

Ar Pest & Vet

ASE:MBED

Ürdün / Malzeme / Kimya

Genel Bakış

10 Yıllık Finansal Veriler

Hisse Fiyatı

2,95 JOD


Key Metrics	Latest
Total Revenue	36,596 M
Adjusted EBITDA	8,35 M
EBITDA Margin	22,8%
Net Profit Margin	20,2%
Total Assets	58,866 M
Total Debt	6,741 M

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months

Revenue	19	20	17	17	20	23	23	24	30	36	37
% Growth		2.3%	-10.9%	-2.5%	15.5%	15.2%	0.3%	7.1%	23.5%	19.3%

Adjusted EBITDA	3	4	3	3	4	5	5	6	7	8	8
% Margin	16.7%	18.1%	19.1%	19.0%	19.6%	23.6%	22.9%	23.0%	22.3%	22.8%	22.8%

Adjusted EBIT	2	3	3	2	3	5	5	5	6	8	8
% Margin	13.0%	14.3%	14.5%	13.8%	16.0%	21.2%	21.1%	21.1%	20.6%	21.3%	21.3%

Adjusted Net Income	2	3	3	3	3	4	4	5	6	7	7
% Margin	12.1%	14.3%	14.9%	14.8%	16.0%	19.5%	19.7%	20.0%	19.3%	20.3%	20.2%

Adjusted Basic EPS	0.15	0.19	0.17	0.17	0.21	0.29	0.30	0.32	0.37	0.44	0.45

Destekleyen Hesaplamalar

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
JOD	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Mar-25
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	19	20	17	17	20	23	23	24	30	36	37
% Growth	NA	2.3%	-10.9%	-2.5%	15.5%	15.2%	0.3%	7.1%	23.5%	19.3%

Cost of Revenue	(14)	(14)	(12)	(12)	(14)	(15)	(15)	(16)	(20)	(24)	(24)
Gross Profit	5	5	5	5	6	8	8	8	10	12	12
% Revenue	25.5%	28.1%	31.0%	31.1%	31.0%	34.7%	35.3%	34.2%	32.7%	33.3%	33.2%

Research and Development	0	0	0	0	0	0	(0)	(0)	(0)	(0)	(0)
Selling and Marketing	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)
General and Admin	(2)	(2)	(2)	(2)	(2)	(2)	(2)	(2)	(2)	(3)	(3)
Other Inc / (Exp)	0	0	0	0	0	0	0	0	0	1	1
Total Operating Exp	(2)	(2)	(2)	(3)	(3)	(3)	(3)	(3)	(3)	(4)	(4)

Operating Income	3	3	3	3	4	5	5	5	7	8	8
% Revenue	15.0%	16.6%	17.3%	16.2%	18.0%	22.2%	22.7%	22.6%	21.9%	22.7%	22.7%

Interest Expense	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)
Pre-tax Income	2	3	3	3	3	5	5	5	6	8	8
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(1)	(1)
Net Income to Company	2	3	3	3	3	4	4	5	6	7	7
% Margin	12.1%	14.3%	14.9%	14.8%	16.0%	19.5%	19.7%	20.0%	19.3%	20.3%	20.2%

Minority Interest in Earnings	(1)	(1)	(1)	(0)	(1)	(1)	(1)	(1)	(1)	(2)	(1)
Net Income to Stockholders	2	2	2	2	2	3	4	4	4	6	6

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0	0	0	0

Net Income to Common	2	2	2	2	2	3	4	4	4	6	6
% Margin	9.1%	11.5%	11.6%	11.9%	12.4%	14.7%	15.7%	16.1%	14.9%	16.0%	16.2%

As Reported
Basic EPS (Continuing Ops)	0.12	0.15	0.13	0.13	0.16	0.22	0.24	0.26	0.29	0.35	0.36
Diluted EPS (Continuing Ops)	0.12	0.15	0.13	0.13	0.16	0.22	0.24	0.26	0.29	0.35	0.36

WA Basic Shares Out.	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.50	16.50	16.50
WA Diluted Shares Out.	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	15.50	16.50	16.50

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	2	3	3	3	3	5	5	5	6	8	8
Addback: Net Interest Expense	0	0	0	0	0	0	0	0	0	0	0
Addback: Other Non Operating Expenses, Total	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)
Addback: Depreciation & Amortization	1	1	1	1	1	1	0	0	0	1	1
Addback: Restructuring Charges	0	0	0	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	0	0	0	0	0	0	0	0	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	0	0	0	0	0	0	0	0
Adjusted EBITDA	3	4	3	3	4	5	5	6	7	8	8
% Margin	16.7%	18.1%	19.1%	19.0%	19.6%	23.6%	22.9%	23.0%	22.3%	22.8%	22.8%

Adjusted EBIT	2	3	3	2	3	5	5	5	6	8	8
% Margin	13.0%	14.3%	14.5%	13.8%	16.0%	21.2%	21.1%	21.1%	20.6%	21.3%	21.3%

Adjusted Net Income Reconciliation
Net Income to Company	2	3	3	3	3	4	4	5	6	7	7
Addback: Unusual Items	0	0	0	0	0	0	0	0	0	0	0
Less: Tax Benefit of Unusual Items (26%)	0	0	0	0	0	0	0	0	0	0	0
Adjusted Net Income	2	3	3	3	3	4	4	5	6	7	7
% Margin	12.1%	14.3%	14.9%	14.8%	16.0%	19.5%	19.7%	20.0%	19.3%	20.3%	20.2%

Yüklenme Hatası

Ar Pest & Vet

ASE:MBED

Ürdün / Malzeme / Kimya

10 Yıllık Finansal Veriler